These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12666073)

  • 1. Insulin resistance as putative cause of chronic renal transplant dysfunction.
    de Vries AP; Bakker SJ; van Son WJ; Homan van der Heide JJ; The TH; de Jong PE; Gans RO
    Am J Kidney Dis; 2003 Apr; 41(4):859-67. PubMed ID: 12666073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic disorders following kidney transplantation.
    Phillips S; Heuberger R
    J Ren Nutr; 2012 Sep; 22(5):451-60.e1. PubMed ID: 22445053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome, insulin resistance, and chronic allograft dysfunction.
    Porrini E; Delgado P; Torres A
    Kidney Int Suppl; 2010 Dec; (119):S42-6. PubMed ID: 21116317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk reduction in renal transplantation. Strategies for success.
    Kiberd BA
    Minerva Urol Nefrol; 2002 Jun; 54(2):51-63. PubMed ID: 12070454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: prevention and treatment.
    Wissing KM; Pipeleers L
    Transplant Rev (Orlando); 2014 Apr; 28(2):37-46. PubMed ID: 24507957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction.
    Hartog JW; Smit AJ; van Son WJ; Navis G; Gans RO; Wolffenbuttel BH; de Jong PE
    Am J Kidney Dis; 2004 Jun; 43(6):966-75. PubMed ID: 15168376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
    Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease and the renal transplant recipient.
    Kendrick E
    Am J Kidney Dis; 2001 Dec; 38(6 Suppl 6):S36-43. PubMed ID: 11729004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Causes of late renal transplant dysfunction].
    Szabó A; Müller V
    Orv Hetil; 2002 Dec; 143(51):2811-9. PubMed ID: 12638307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic sleeve gastrectomy: gateway to kidney transplantation.
    Kienzl-Wagner K; Weissenbacher A; Gehwolf P; Wykypiel H; Öfner D; Schneeberger S
    Surg Obes Relat Dis; 2017 Jun; 13(6):909-915. PubMed ID: 28216112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of obesity on renal transplant outcomes.
    Armstrong KA; Campbell SB; Hawley CM; Johnson DW; Isbel NM
    Nephrology (Carlton); 2005 Aug; 10(4):405-13. PubMed ID: 16109090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinuria 1 year after renal transplantation is associated with impaired graft survival in children.
    Rosík T; Chadimová M; Dušek J; Háček J; Šimánková N; Vondrák K; Zieg J; Seeman T
    Pediatr Nephrol; 2015 Oct; 30(10):1853-60. PubMed ID: 25925040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-Transplant Assessment of Vascular Calcification as a Risk Factor of Mortality, Graft Loss, and Cardiovascular Events in Renal Transplant Recipients.
    Munguia P; Caramelo R; Rubio MV; Sahdalá L; Arnaudas L; Paul J; Blasco Á; Lou LM; Aladren MJ; Sanjuan A; Gutierrez-Dalmau A
    Transplant Proc; 2015 Oct; 47(8):2368-70. PubMed ID: 26518929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercoagulability in renal transplant recipients. Identifying patients at risk of renal allograft thrombosis and evaluating strategies for prevention.
    Irish A
    Am J Cardiovasc Drugs; 2004; 4(3):139-49. PubMed ID: 15134466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney Transplantation: A Population Cohort Study.
    Lim WH; Johnson DW; Hawley CM; Pascoe E; Wong G
    Am J Kidney Dis; 2018 Jan; 71(1):102-111. PubMed ID: 29191625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.
    de Mattos AM; Olyaei AJ; Prather JC; Golconda MS; Barry JM; Norman DJ
    Kidney Int; 2005 Feb; 67(2):714-20. PubMed ID: 15673321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues of obesity in kidney transplantation.
    Kent PS
    J Ren Nutr; 2007 Mar; 17(2):107-13. PubMed ID: 17321949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction.
    Mikolasevic I; Racki S; Lukenda V; Pavletic-Persic M; Milic S; Orlic L
    Med Hypotheses; 2014 Jan; 82(1):36-9. PubMed ID: 24280560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucometabolic disease in the kidney transplant patient.
    Sadhu AR; Steenkamp D; McDonnell ME
    Front Biosci (Schol Ed); 2016 Jan; 8(1):67-78. PubMed ID: 26709897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.